نتائج البحث

Structure-based non-nucleoside inhibitor design: Developing inhibitors that are effective against resistant mutants.

• Authors : Smith SJ; HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.; Pauly GT

Subjects: Drug Design* ; Drug Resistance, Viral*/Drug Resistance, Viral*/Drug Resistance, Viral*/drug effects ; Pyridones*/Pyridones*/Pyridones*/pharmacology

• Source: Chemical biology & drug design [Chem Biol Drug Des] 2021 Jan; Vol. 97 (1), pp. 4-17. Date of Electronic Publication: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101262549 Publication Model: Print-Electronic Cited

تفاصيل العنوان

Comparative study on the replication of HCV1b genome between wild-type and cell culture-adaptive mutant in regard to sensitivities against anti-HCV drugs.

• Authors : Miyayama Y; Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.; Graduate School of Biostudies, Kyoto University, Kyoto, Japan.

Subjects: Drug Resistance, Viral* ; Virus Replication*; Hepacivirus/Hepacivirus/Hepacivirus/*physiology

• Source: Microbiology and immunology [Microbiol Immunol] 2020 Apr; Vol. 64 (4), pp. 296-303. Date of Electronic Publication: 2020 Jan 31.Publisher: Wiley-Blackwell Country of Publication: Australia NLM ID: 7703966 Publication Model: Print-Electronic Cited

تفاصيل العنوان

Systematic review with meta-analysis: impact of baseline resistance-associated substitutions on the efficacy of glecaprevir/pibrentasvir among chronic hepatitis C patients.

• Authors : Singh AD; Department of Internal Medicine, Cleveland Clinic, Cleveland, OH, USA.; Maitra S

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*administration & dosage ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*administration & dosage ; Drug Resistance, Viral/Drug Resistance, Viral/Drug Resistance, Viral/*genetics

• Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2020 Mar; Vol. 51 (5), pp. 490-504. Date of Electronic Publication: 2020 Jan 14.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

Hepatitis C reinfection with protease inhibitor-resistant hepatitis C virus in an HIV-coinfected MSM.

• Authors : Yilmaz GR; Faculty of Medicine, Suleyman Demirel University, Infectious Diseases and Clinical Microbiology, Isparta, Turkey.; Department of Medicine I, University Hospital Bonn, Bonn, Germany.

Subjects: Drug Resistance, Viral*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Coinfection/Coinfection/Coinfection/*drug therapy

• Source: Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2020 Jan; Vol. 40 (1), pp. 47-50. Date of Electronic Publication: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101160857 Publication Model: Print-Electronic Cited

تفاصيل العنوان

Entecavir resistance mutations rtL180M/T184L/M204V combined with rtA200V lead to tenofovir resistance.

• Authors : Jiang D; Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.; Beijing Key Laboratory of Emerging infectious Diseases, Beijing, China.

Subjects: Drug Resistance, Viral*; Guanine/Guanine/Guanine/*analogs & derivatives ; Hepatitis B virus/Hepatitis B virus/Hepatitis B virus/*genetics

• Source: Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2020 Jan; Vol. 40 (1), pp. 83-91. Date of Electronic Publication: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101160857 Publication Model: Print-Electronic Cited

تفاصيل العنوان

High efficacy of sofosbuvir/velpatasvir and impact of baseline resistance-associated substitutions in hepatitis C genotype 3 infection.

• Authors : von Felden J; Hamburg, Germany.; New York City, NY, USA.

Subjects: Drug Resistance, Viral*/Drug Resistance, Viral*/Drug Resistance, Viral*/drug effects ; Drug Resistance, Viral*/Drug Resistance, Viral*/Drug Resistance, Viral*/genetics; Carbamates/Carbamates/Carbamates/*administration & dosage

• Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2018 May; Vol. 47 (9), pp. 1288-1295. Date of Electronic Publication: 2018 Mar 14.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

Genome characterization of influenza A and B viruses in New South Wales, Australia, in 2019: A retrospective study using high‐throughput whole genome sequencing.

• Authors : Wang, Xinye^1,2 (AUTHOR); Kim, Ki Wook^2,3 (AUTHOR); Walker, Gregory^1,2 (AUTHOR)

• Source: Influenza & Other Respiratory Viruses. Jan2024, Vol. 18 Issue 1, p1-13. 13p.

تفاصيل العنوان

Tenofovir disoproxil fumarate has a substantial efficacy against multidrug-resistant strains of hepatitis B virus.

• Authors : Baran B; Department of Gastroenterology, Koç University Hospital, Zeytinburnu, Istanbul, Turkey.; Soyer OM

Subjects: Drug Resistance, Viral*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*administration & dosage ; Hepatitis B virus/Hepatitis B virus/Hepatitis B virus/*drug effects

• Source: Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2015 Oct; Vol. 35 (10), pp. 2265-74. Date of Electronic Publication: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101160857 Publication Model: Print-Electronic Cited

تفاصيل العنوان

Sorting out cirrhosis: mechanisms of non-response to hepatitis C therapy.

• Authors : Al Marzooqi SH; Toronto Centre for Liver Disease, University of Toronto, Toronto, ON, Canada.; Feld JJ

Subjects: Drug Resistance, Viral*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Hepacivirus/Hepacivirus/Hepacivirus/*drug effects

• Source: Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2015 Aug; Vol. 35 (8), pp. 1923-33. Date of Electronic Publication: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101160857 Publication Model: Print-Electronic Cited

تفاصيل العنوان

miR146a impairs the IFN-induced anti-HBV immune response by downregulating STAT1 in hepatocytes.

• Authors : Hou ZH; Institute of Immunopharmacology & Immunotherapy, School of Pharmaceutical Sciences, Shandong University, Jinan, China.; Han QJ

Subjects: Drug Resistance, Viral*/Drug Resistance, Viral*/Drug Resistance, Viral*/genetics; Antiviral Agents/Antiviral Agents/Antiviral Agents/*pharmacology ; Hepatitis B virus/Hepatitis B virus/Hepatitis B virus/*drug effects

• Source: Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2014 Jan; Vol. 34 (1), pp. 58-68. Date of Electronic Publication: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101160857 Publication Model: Print-Electronic Cited

تفاصيل العنوان